2025-12-31-accounts

Registered company nutnber: 10287079 (England and Wales) Reg]￿ered charity number.. 1177540 Report ofthe Trusiecs and Unaudited fiiiancial Stateiiients for the year end¢d 31 tk¢ei))b¢r ?025 for JCCP la compan). limi*d bi 8uardnieel

JCCP (limited by guarantee) Contents of the FiMancial Statements lor the year ended 31 Deeember 202. Page Re￿)rt i)lthe Tru8i¢e% 1-53 Inde￿nd¢nt F￿￿ine￿4 Report Siai¢Tn¢nt ()f FinaDLial Acti￿.111¢5 55 U1(￿L¢ %h¢el Nol¢s lu th¢ FinunLiiil Siat¢rnents 5741)

JCC'P Ilimited by guarantee) lthftsrmtiott Pgt for the year ended 31 Dteember 2025 The Ir￿￿￿8. who gr¢ #lsth dirntnrq of the th¢ purrKw of th¢ CtyThparti¢s A¢¢ 2￿6. present thtir report with the linaniial SthlCMc￿ts ofihc Chan￿ foT Ehclraiendcd 31 DccenLiKt j025. Tht Irusiees hav¢ adtsp￿d Iht pthiS￿n$ of tht Chan"rs Stsknntni of R¢ethnmend¢d Pra¥liet ISORPI "Ac¢ounlin8 and Rewrting by Clwrties. effective JanuaTr'2019. RF.FF.RF.NC'F. AWD.4DIII%ISTRATIVF. DF.T.41JS Registered C-ompni jumbtr 10287079 I￿.￿BlaThd and Il'ales ReRlsiered C'hriiy ReRistered Offtet L'vmpJss Point Thsi￿ SoiiihJmpLon %()314RA l)Ire¢ior% #Dd'frusie¢s k C'airL% l.'W Ilvok'¢r l)r (' kiLI l)r M kin8 D Kni8hi )rofMJ I.O%C8Tove ANI Rankin SM'I at¢r PrDI'J LIn&N￿od Independtnl b'.imln¢r J BaTdvlph AL'A. PC'C'A. BFP Ltd C'ompas5 Poinl Ensi8J Hamblc Soiilhampton H&iiip8hue S0314RA

Charity Commission Number 1177540

Trustees /26 JCCPAnnuaS Report

Voting Members

Professor David Sines CBE – Chairperson and Registrar (Resigned February 1st 2026) Dr. Martyn King – Medicine – Vice Chair

Dr. Tracey Bell – Dentistry

Eddie Hooker – Corporate Governance Dawn Knight – Patient Advocate/Service User (Resigned 28th February 2026) Kimberley Cairns – Patient/User Advocate Victoria Brownlie MBE - Beauty Therapy Sector Professor John Underwood – Chair Communications and Marketing Committee Professor Mary Lovegrove OBE – Chair of the Education and Training Committee (Resigned 1st February 2026)

Andrew Rankin – Nursing and Chair of the Practitioner Register Committee and CoChair Clinical Advisory Group

Sally Taber – Corporate Governance

Dr. Clare Kiely – Consultant Dermatologist and CPSA Representative CPSA Representative

Dr Paul Charlson – Medicine (Resigned November 10th 2025) Dr John Elder – Medicine (BCAM nominated Trustee) Brenda McKibben - (BACN nominated Trustee) Dr. Catherine Fairris (Appointed December, 2025)

Non-Voting Members

Victor Ktorakis – Environmental Health Sector Representative Lukasz Adamek - Manufacturing Industry Representative (Galderma) Cheryl Pitcher/Dr. Maria Christidou - Manufacturing Industry Representative (Allergan) Joan Scott – Skills Active/Habia

Gillian Kennedy - Manufacturing Industry Representative (Merz) Mark Hope – Chartered Institute of Environmental Health Dr. Elaine Sassoon – BAAPS representative Sharron Brown – Nursing

Executive Support

Paul Burgess MBE

Project Development Officer

Zoe Cooper

2025/26 JCCP Annual Report

Trustee Appointment Process

Trustee Appointment Process

All voting members of the JCCP Trust Board are appointed in accordance with Charity Commission rules and procedures in strict accordance with Nolan Principles. All voting members of the Trustee Board are also registered with Companies House. All appointments are approved by the full Trustee Board in open session.

Non-Voting members are selected and appointed in accordance with ‘skill mix/expertise’ requirements determined by the full Trustee Board in order to enable the Board to achieve its core purpose, functions and objectives.The JCCP operates as an inclusive and non-discriminatory organisation.

2025/26 JCCP Annual Report

Mission Statement, Values and Public Protection

Mission Statement of the JCCP

‘The Joint Council for Cosmetic Practitioners (JCCP) is recognised as a selfregulator of the non-surgical aesthetic and hair restoration surgical sector in England and a point of access for the public seeking information about this area of practice and where appropriate for raising concerns about practitioners and educational providers. The JCCP places public protection and patient safety at the core of its activities.

JCCP Practitioner Registrants and associated Education and Training Providers and Qualifications are approved by the JCCP following recommendation from the Education and Training Committee as meeting the highest standards of quality by ensuring that all parties who have been admitted to the JCCP’s Register(s) have met agreed benchmarks and abide by the standards of practice and behaviour as determined by the Cosmetic Practice Standards Authority (CPSA) and the JCCP.

Values of the JCCP

• Upholding Patient Safety and Public Confidence as the core driving force of the JCCP.

• Operating its Register of Practitioners (as required by the Government’s Professional Standards Authority) and its Register Approved Education and Training Providers within a strict and agreed Code of Practice and Competency Framework that embodies robust ethical standards to providing aesthetic treatments and education and training.

• Openness, fairness, and independence.

• Commitment to Equality of Opportunity, Inclusion and Diversity

• Working in partnership with service users and all key stakeholders in the aesthetic industry.

• Recognising innovation and best evidenced-based practice and responding constructively to service change and development.

2025/26 JCCP Annual Report

Protecting the Public

• Applying strict standards for entry to the JCCP Register and for continued registration (as required by the Government’s Professional Standards Authority).

• Approving qualifications and education and training providers that deliver qualifications that meet the standards.

• Maintaining a register of individuals who successfully complete those programmes and approval procedures.

• Taking action if the standards may not have been met through the application of the JCCP’s published Fitness to Practice Standards.

• Establishing clear and simple procedures to enable the public to raise issues of concern about the professional practice of registrants or other key issues of concern related to aesthetic education, training and standards of aesthetic practice.

• Providing simple and easily accessible information to members of the public considering non-surgical aesthetic treatments.

• Informing professional regulators and government agencies in relation to areas of risk in the sector and of the opportunities to mitigate such risks.

2025/26 JCCP Annual Report

JCCP.Strategi Objective JCCPAnnual Re

Strategic Objective 1

To continue to sustain a self-regulatory body to oversee the non-surgical aesthetic sector and the hair restoration surgical sector in England with a clear and supported framework of governance.

Key Enablers

• Dissemination and application of education, clinical and practice-based standards for non-surgical aesthetic and hair restoration surgical treatments. Implementation of an agreed set of premises standards for practitioners and education/training providers.

• Oversight and governance of a constitutional structure that befits a selfregulatory body with charitable status.

• Scrutiny, compliance, and assurance in alignment of the JCCP published governance framework.

• Dissemination and application of an agreed ‘Code of Practice’ (2023) for Registrants (in partnership with the CPSA).

• Publication and implementation of clear and transparent procedures and processes for dealing with ‘complaints’ or ‘fitness to practice’ issues.

• Ongoing agreement and alignment of frameworks and best practice for working with ‘Professional Statutory Regulatory Councils’ regulating practitioners in the fields of non-surgical aesthetics and hair restoration surgery.

• Implementation of the agreed Executive and administrative structure for the JCCP.

• Ensuring and monitoring continuous risk management.

• Continue to implement and update CPSA standards framework and where necessary reflect any updates and additions of ‘emergent therapies’ in JCCP processes, procedures and competency frameworks.

• Review the JCCP Competency Framework in line with any changes in standards agreed by the JCCP/CPSA in association with emergent standards set down by the DHSC as part of proposed national licensing requirements in England.

• Carry out Annual Governance reviews in line with requirements from the PSA, Companies House, and the Charity Commission.

• Maintain and update the JCCP Register of Trustees and appointments to other JCCP committees.

• Maintain a central register of JCCP appointees ‘Declarations of Interest’.

• Introduce robust arrangements for succession planning for the Council and its Committees.

2025/26 JCCP Annual Report

Strategic Objective 2

To deliver the JCCP as an organization and brand that is recognised by the public and by practitioners as the benchmark for patient safety in non-surgical aesthetic and hair restoration surgery treatments and services.

Key Enablers

• Establishing and disseminating the JCCP brand and narrative that is clearly recognisable.

• Setting out the key purpose of the JCCP as a guardian of patient safety and public protection and establishing it as a company limited by guarantee with charitable status.

• Publishing and reinforcing the key practitioner entry requirements to the JCCP Practitioner Register to ensure public confidence.

• Implementing a ‘Marketing and Communications Strategy’ and accessible ‘public facing’ website to raise public awareness of the JCCP.

• Appoint a cadre of expert Key Opinion Leaders and Ambassadors to support and advocate on behalf of the JCCP and its mission.

• Providing an accessible JCCP Practitioner Register and associated tools to enable the public to identify practitioners who meet the required standard. Publication and active promotion of the benefits of meeting practitioner entry requirements and registration on the JCCP register.

• Continue to work with UK Government Departments, the PSA, the CQC, HIS, the MHRA, CIEH, PSRBs, the ASA with Professional Membership Associations to promote the co-design, development, and implementation of a robust and responsive system of statutory governance and quality control in the Aesthetics Sector. The JCCP and the CPSA will seek (together) to maintain active and full engagement with the Government and UK devolved nations to inform the codesign and implementation of regulation and licensing for the non-surgical cosmetic sector in England and Scotland by 2027. To work also with the Welsh and Northern Ireland Assemblies to inform a new system of

• regulation/licensing for non-surgical cosmetic interventions in these devolved nations. JCCP structures and resources will be reviewed and enhanced to facilitate and enable the Council’s active contribution to assist in the design of a new model for regulation and licensing for both practitioners and premises.

2025/26 JCCP Annual Report

Strategic Objective 3

To monitor the effective establishment and implementation of the JCCP Practitioner Register (s) as required by the PSA as an approved public register (s) for practitioners in the non-surgical aesthetic and hair restoration surgery sectors.

Key Enablers

• Implementing, managing, and monitoring the outcomes of a systematically applied audit of the Practitioner Register (s) to meet PSA standards. Achievement of annual PSA accreditation (including EDI compliance). Providing robust JCCP technology platforms for its registers.

• Undertaking regular market testing with key stakeholders regarding the JCCP’s operating platforms and procedures.

• Updating the JCCP Practitioner Register to reflect continuous quality improvement/performance requirements.

Strategic Objective 4

4a - To approve non-surgical aesthetic and hair restoration surgery qualifications and education and training provider organisations against an agreed, framework of education, clinical and practice standards for non-surgical aesthetics and hair restoration surgery treatments and procedures and to maintain a published register of the same.

4b - To review and revise the JCCP Education and Training Competency Framework in a timely and responsive manner in accordance with any changes mandated by the DHSC/Devolved nations as part of the Governments’ proposed implementation of a regulation and licensing scheme for non-surgical cosmetic procedures in the UK.

Key Enablers

• Disseminate, publish and apply entry requirements and structures for education and training provider organisations to join the Council’s Register of Approved Education and Training providers.

• Implement, monitor and update the JCCP’s framework of educational, clinical and practice-based standards against which to register practitioners.

2025/26 JCCP Annual Report

• Implement processes for evaluating and approving qualifications and education and training provider organisations that meet the JCCP standards. Implement and monitor the JCCP’s framework of educational, clinical and practice-based standards against which to accredit practitioners. Implement processes for accrediting education and training provider organisations that meet the JCCP standards via approved centres. Establish working arrangements with key education and training provider organisations and vocational Awarding Organisations approved to deliver JCCP approved qualifications.

• Continue to monitor the implementation and ‘roll out’ of the JCCP’s approved alignment of designated Specialist Register (and professional College) competencies/standards against the JCCP Competency Framework. Alignment of Professional Specialist Registry and BCAM Competencies with the JCCP Competency Framework. Recognition and approval of the BAMAN education and training competence framework.

• Maintain effective working relationships with other key regulatory, accreditation and awarding bodies working in non-surgical aesthetics, including the Government’s regulators for qualifications – Higher Education Institutions, Ofqual, the SQA and Skills England (for the alignment of national apprenticeship standards) etc.

• To work with the College of General Dentistry to support the design and implementation of a scheme of credentialing for registered dental practitioners working in the field of applied facial aesthetics.

2025/26 JCCP Annual Report

Strategic Objective 5

To implement and sustain a viable and sustainable financial model for the JCCP.

Key Enablers

• Continue to identify key sources of income – Registrants, Education and Training providers, Corporate Supporters, Charitable Trusts, public sector organisations.

• Publishing and implementing a charitable funds/fundraising strategy Setting fees education and training provider organisations.

• Setting and monitoring a financially viable budget for the JCCP. Projecting and managing cashflow.

• Continue to implement the ‘Insurers Registration Project’ programme. Continue to promote, embed and extend the JCCP Corporate membership programme.

Strategic Objective 6

To ensure the robust implementation of the necessary technical infrastructure to operate an effective and resilient membership-based charity and regulatory body and register (s).

Key Enablers

• Specifying and procuring the technology requirements for the JCCP Register(s).

• Monitoring the effectiveness of the JCCP technology platforms. Continuously updating and refining the functionality and effectiveness for registration and supporting processes.

• Updating and refining the functionality and effectiveness of the JCCP website and social media functions to ensure ‘reach’ and utilisation.

• Continuing to work in independent association and alignment with with HFR (the JCCP’s contracted website and register host organisation) – contract now renewed for a further three years until April 2028.

• Continue to work in partnership with the CPSA and NEC Software Solutions (previously Northgate) to ensure patient data is collected and analysed to inform the future evidence base for the sector.

2025/26 JCCP Annual Report

Strategic Objective 7

To ensure that the JCCP is a well informed and relevant body in the world of nonsurgical aesthetics and hair restoration surgical practitioners.

Key Enablers

• Continuing to raise awareness of the role of the JCCP and the CPSA amongst key stakeholders.

• Disseminating information to members of the public via its public facing web site – JCCP&me.

• Publishing regular and updated narrative statements that supports and reinforces the Council’s strategic objectives over the next 3 years.

• Hosting regular stakeholder engagement Council meetings and webinars to inform and to seek constructive engagement with the aesthetics sector. Engaging in regular discussion with key sector influencers and political opinion leaders and policy makers with the aim of improving patient care, public protection, and regulation.

• Facilitating ongoing dialogue with system regulators across the UK with the aim of co-designing and implementing pragmatic and effective systems of licensing and regulation for the industry to ensure patient safety and public protection.

• Providing and disseminating up to date information on all aspects of nonsurgical aesthetics and hair restoration surgery for both stakeholders, registrants, and the public.

• Attending national conferences and trade shows/exhibitions to promote

• matters relating to patient safety and public protection in association with the work of the JCCP.

• Continue to publish regular papers, articles and columns in the press and media; to inform and participate in webinars, radio, and TV media broadcasts to promote the JCCP’s quest to promote patient safety and public protection. Reviewing and analysing the latest policy and research relating to the aesthetics sector.

• Providing feedback to the DHSC, Devolved UK Government Departments, PSA, CPSA, MHRA and to the CQC on issues and actions that may lead to an updating of the JCCP/CPSA standards framework.

• Maintaining and updating the JCCP Competency Framework for aesthetic standards as required in accordance with national policy guidance.

2025/26 JCCP Annual Report

• Implementing a range of mechanisms and actions to keep registrants informed about the relevance of the JCCP and the CPSA and the latest issues relating to patient safety and public protection (i.e., through publication of regular newsletters).

• Work with regulators to implement robust standards and regulation for safe, ethical, and professional prescribing.

• Pursuing and complete the implementation of all actions arising from the JCCP 2021 Ten Point Plan and various political campaigns to ensure the full implementation of the Government’s proposed licensing scheme in England: working also with the devolved administrations in Scotland, Wales and Northern Ireland to inform and support national policy development and standard setting.

• Engaging in UK political campaign awareness raising in the interests of patient safety and public protection.

Strategic Objective 8

To deliver and maintain the JCCP complaints system for both internal issues and regarding practitioners and other bodies.

Key Enablers

• Continue to implement and review the JCCP’s published complaints policy. Undertake a review of the ‘filters’ to be applied to all complaints received by the JCCP to prioritize consideration of the same.

• Commission an independent review of the JCCP’s complaint’s portal and implement a new interactive on-line system to enhance productivity and effectiveness.

• Continue respond to complaints about JCCP registrants and approved education and training providers using the agreed (published) JCCP processes. Continue to encourage members of the public (and others) to raise issues of concern and complaints to the JCCP through the medium of the JCCP on-line complaints portal.

• Provide feedback on complaints about JCCP registrants to the PSA and where necessary appropriate regulatory bodies.

• Record and respond to all complaints received and determine if any of these need reporting to other regulators and/or the ASA.

• To collate and analyse complaints data that may have implications for public safety as an evidence basis for change and service improvement.

2025/26 JCCP Annual Report

&••• Introductio 2025/26 JCCPAnnual Report

The Joint Council for Cosmetic Practitioners (JCCP) Charity was established and launched formally at the House of Peers in February, 2018 following an extensive stakeholder consultation process undertaken by Health Education England (HEE) in accordance with the recommendations outlined in the Keogh Review (2013) on cosmetic treatments in England. The HEE standards were formally transferred to the JCCP by HEE in June, 2018 as advised on the NHSE website). One of the key recommendations included in the 2015 HEE Report called for the establishment of statutory regulation for the sector and for the immediate creation of a voluntary register. The JCCP now fulfils such a function.

The JCCP is a ‘not for profit’ UK charitable body charged with the responsibility of voluntary ‘self-regulation’ of the non-surgical aesthetic and hair restoration surgical sectors in the four UK countries. The Mission Statement for the JCCP and its values are set out below:

‘The Joint Council for Cosmetic Practitioners (JCCP) is a Professional Standards Authority (PSA) accredited voluntary self-regulator of the non-surgical aesthetic and hair restoration surgery sector in England and provides an informed and legitimate point of access for the public seeking information about this area of practice and where appropriate for raising concerns about practitioners. The JCCP places public protection and patient safety as the focus of its activities’.

The Charity's objects refer to the promotion of the health and safety of, and protection of the public by the development and implementation of high standards of performance and practice among non-surgical cosmetic practitioners and hair restoration surgeons, including the definition, creation, and maintenance of an effective structure to inform the standard of professional education and training amongst non-surgical cosmetic practitioners and hair restoration surgeons.

The JCCP provides two voluntary registers;

• Practitioner Register (Approved by the PSA)

• Approved Qualifications and Education & Training Provider Register (Approved by the JCCP and lists those education and training provider organisations and qualifications that have been submitted to the JCCP for approval and whose standards and qualifications accord with the JCCP’s published education and training standards required for full entry to its PSA Approved Practitioner Register).

2025/26 JCCP Annual Report

JCCP Practitioner Registrants (who are appointed in accordance with PSA accreditation standards) and Approved Qualifications, Education and Training Provider Organisations are recognised, approved, and registered by the JCCP in line with JCCP/CPSA accredited standards. For practitioner registrants this requires evidence of the possession of relevant knowledge, experience or qualifications leading to core and modality specific competency as set out by the JCCP’s sister body the Cosmetic Practice Standards Authority in their practice standards (February, 2018) and by the JCCP’s Competency Framework (September, 2018), adherence to a published Code of Practice and Standards set out by the JCCP/CPSA (2023), good character, compliance with premises/infection control/health protection standards and possession of adequate insurance and indemnity cover in relation to treatments provided.

The JCCP has continued to function as a productive and influential charitable organisation throughout 2025/2026 and has engaged regularly with the UK Government, UK Devolved Government Administrations, National Government Agencies, Professional Statutory Regulatory Bodies, Other Regulators (such as the CQC and MHRA), Professional Membership Associations, Insurance Companies, Pharma Companies, Pharmacies and Professional Stakeholder Organisations in order to advise, determine and publish guidelines on how to work safely, ethically, professionally, and legally within the aesthetics sector. The JCCP has again regularly contributed this year to a range of regional, national and global webinars, published standards and guidance on its website and responded to numerous individual and corporate enquiries during the reporting year with particular regard to governance and regulatory reform within the aesthetics sector. This work has dominated much of the JCCP’s activity and stakeholder engagement activities.

The transaction of the JCCP’s functions is dependent upon receipt of charitable donations received from a wide range of stakeholders in the form of pro bono goods and services and in the form of financial contributions. The JCCP gratefully acknowledges the significant support and charitable assistance provided by its multiple sponsors: [Allergan] AbbVie PLC; Bevan Brittan LLP; Clinisept+; Church Pharmacy Ltd; HealthXchange; Galderma Ltd; Hamilton Fraser Resolutions Ltd; Harley Academy; Merz Ltd; NEC Software Systems; Teoxane, sk:n Clincs - (Optical Express) and HealthXchange Pharmacy.

The JCCP has continued to receive executive support from Paul Burgess. Administrative support has been provided via a paid contract by the Hamilton Fraser Administrative Team. Zoe Cooper - the JCCP’s Project Development Officer has also transformed the way in which the JCCP functions both operationally and through our multiple media channels. The Council’s financial management,

2025/26 JCCP Annual Report

accountancy and audit services are outsourced to independent accountancy companies. Social media and communications and the management of the JCCP website have been brought ‘in-house’ this year under the expert oversight of Zoe Cooper, JCCP Project Development officer. The JCCP has also procured website advice and technical support via direct contract. Pro bono legal advice has been provided to the JCCP again this year by our legal advisors Bevan Brittan.

The JCCP’s full time Project Development Officer during the reporting year, Zoe Cooper was contracted on a full time basis throughout the reporting year. Zoe Cooper has enabled the Council to achieve the following key service improvements:

• Update and maintenance of the JCCP’s public facing website – JCCP & me Continued redesign and upgrade to the JCCP website and policy/procedural document

• Provision of administrative and software system support for the JCCP’s education and training provider application process

• JCCP event management, marketing and communication

• Design and management of the JCCP’s social media activities, platforms and processes

• Support to design and provide documents required for achieved PSA accreditation (2025-2026)

• Design and procurement of a new digitally enhanced online complaints portal for members of the public

• Management of the JCCP’s ‘Share point’/Client Management System and communication databases

• Provision of support for the design and implementation of the JCCP’s marketing and communication strategy, including the production of Registrant and Public facing newsletters, articles, webinars and marketing materials.

2025/26 JCCP Annual Report

Developments 2025126 JCCP Annual Report

The JCCP has been functioning for eight years at the time of producing this annual report. During the past twelve months the JCCP has continued to formally enhance and embed its governance structures and has retained a fully appointed representative Board of Trustees, all of whom are registered with the Charity Commission and Companies House. Conflicts of interest policies and confidentiality procedures continue to be implemented and enforced to guide the work of the Charity. No significant breaches of confidentiality or governance have been witnessed during this year’s reporting period. A ‘Declaration of Interests’ register and risk registers are kept centrally and was updated in June, 2025. Conflicts of interest have been overtly declared where relevant and have been reported to the Trustee Board through the exercise of the Charity’s public duty and candour process. During the reporting year the JCCP has continued to publish the minutes of its Trustee Board on its public facing website to enable transparency and accessibility to members of the public. The JCCP also published its Annual Report (2024/25) and Accounts on its public facing website in July, 2025. The JCCP operates two risk registers (relating to patient safety and corporate governance) and reviews these at each Trustee meeting. During the past year the JCCP’s policies and operating procedures have been formally reviewed and confirmed as being ‘fit for purpose’.

The JCCP implemented a new ‘Oversight Committee’ during the reporting year, which is chaired by the Council’s Vice Chair – Dr. Martyn King. The functions of the Committee have been determined to:

(a) to review the financial statements of the JCCP and significant financial reporting policy issues.

(b) to advise on the adequacy of the Organisation’s internal controls and risk management systems, and to review risk assessment in the organisation and the comprehensiveness of existing process for risk management.

(c) to exchange information with, and review the effectiveness of, the organisation’s sub committees.

(d) to provide, upon request, advice to the Executive Chair and Registrar on crosscutting or strategic issues not covered by other Committees.

(e) to assume responsibility for succession planning and appraisal of JCCP appointed Trustees.

(f) toreview/make recommendations for applications for JCCP corporate sponsorship.

(g) to prepare an annual report on the activities of the JCCP, conclusions, recommendations and, where necessary, interim reports on key areas of concern.

(h) to oversee key policy areas and strategic issues concerning the development of

2025/26 JCCP Annual Report

the JCCP as recommended by the Trustee Board and/or the Executive Chair and Registrar.

(i) to ensure that the JCCP develops its activities in line with the strategic needs of the non-surgical sector and in particular oversee arrangements for the proposed new licensing schemes in England and any changes in the rest of the UK.

(j) to ensure that the JCCP has the necessary resources it requires to deliver its functions.

(k) to oversee the effectiveness of the JCCP Operational Plan.

(l) to make recommendations to the JCCP Trustee Board and or JCCP sub committees on the outcome of oversight activities.

The Oversight Committee has played a pivotal role during 2025/2026 in the discharge of these functions and reported regularly to the full JCCP Trustee Board. In particular the Oversight Committee has led on succession planning, Trustee appraisal and on the design and procurement of a new digitally aligned complaints portal to designed to assist the Council to transact and more effectively manage its patient/stakeholder complaints reporting systems.

The JCCP Practitioner Register Committee (PRC) has continued to meet at bimonthly intervals throughout the reporting year under the Chairmanship of Andrew Rankin and has received ongoing legal advice from Bevan Brittan following the full implementation of the Council’s Fitness to Practise Rules and procedures. The full ‘suite of’ policies and procedures governing the JCCP’s FtP continue to be regarded as ‘fit for purpose’. The JCCP’s list of ‘fitness to practise’ panellists (who are appointed by an independent Appointments Committee on behalf of the Council) has been updated again this year and the Panellists continue in their role and provide a fully representative group of lay and professional FtP panel members. All Panellists have been trained in the application of the Council’s FtP processes. The JCCP Practitioner Register Committee also complied with the annual audit/sampling of registrant’s self-returns for premises standards,

supervision and for CPPD. The fourth annual sample of Registrants was completed in October, 2025 in accordance with agreed procedure. The sampling process continues to provide an effective method to quality assure practitioner annual renewal of registration requirements. During 2025 the PRC has continued to undertake regular bi-monthly audit to ensure the accuracy of Registrant data that appears on the JCCP public facing Practitioner Register. Upgrades and

improvements have been made throughout the year to the Practitioner Register’s data base and operating system to enable more effective data processing and coding as required. Bi-monthly ‘deep dives’ have also been undertaken by a subcommittee of the JCCP in partnership with the Register Administration team during the reporting year to scrutinise registration data integrity and accuracy. The

2025/26 JCCP Annual Report

JCCP Registrar and the Chair and Vice-Chair of the JCCP Practitioner Register Committee attend and participate in all ‘deep dive’ meetings.

Throughout the year the JCCP Practitioner Register Committee provided rigorous oversight for the maintenance of the PSA approved Part ‘A’ – ‘Category Two’ registration category for health care professionals. Revised definitions for these categories have been published on the JCCP website. Due to anticipated changes being made by the UK Government on the implementation of new education and training standards for the aesthetic sector in England the JCCP sought agreement from the PSA in September, 2022 to extend the period for which the ‘Part A’ – ‘Category Two’ may stay open until the Government publishes its education and training standards and makes an explicit determination on its plans for the implementation of a new system of licensing for the aesthetics sector. The PSA conceded to this request. This concession has remained in force again throughout the reporting year and will do so until the DHSC/Scottish Government confirm their definitive proposals for a legally enforceable licencing scheme for nonsurgical cosmetic practitioners in England.

The JCCP continues to enforce its standards and procedure to enable the collection of designated data relating to equality, diversity and inclusivity for its Registrants. The JCCP Executive Chair and Registrar and the Chair of the Practitioner Register Committee have met at bi-monthly intervals with the JCCP Register team to review EDI data returns/data and consider the ‘EDI’ representativeness of the JCCP Practitioner Register.

During the 2025/2026 reporting year the JCCP received one formal complaint against a Practitioner Registrant. The complaint was formally investigated in accordance with the JCCP’s published Fitness to Practice procedures. The complaint was formally investigated in accordance with the JCCP’s Memorandum of Understanding with the NMC. The NMC determined that there was no evidence of an official breach of their Code of Practice. Following referral to the JCCP’s independent Chair of the Fitness to Practice Committee the JCCP reached a similar (independent) determination regarding the JCCP Code of Practice (2023). The JCCP Registrant was however reminded of their duty to abide by the JCCP Code of Practice (2023) and to ensure compliance with the JCCP’s statement regarding expected standards relating to the use of social media.

The JCCP continues to recruit to its Practitioner Register. By the end of December, 2025, the total number of registrants was reported to be 1,100. The JCCP Council considers that continuing to work in alliance with aesthetic insurers is a practical and logical step to encourage and develop safe practice and practitioners. The

2025/26 JCCP Annual Report

JCCP continues to believe that by increasing the number of Registrants on its Practitioner Register, their confirmation to practise in accordance with both CPSA and JCCP standards will further assist us in meeting our aim of assuring public safety and will provide Registrants with a ‘gateway’ towards the achievement of the Government’s Practitioner regulatory/licensing schemes in England and Scotland when they comes into force in 2026/2027.

The JCCP has decided to continue to offer free membership to all practitioners who meet agreed JCCP standards.

Throughout the year the Council has implemented robust systems of data integrity audit to ensure that public facing data relating to Registrants is accurate in compliance with PSA standards and requirements.

The JCCP has also continued to restrict access to its Level 7 practitioner register for Injectable Toxins, Fillers and Hair Restoration Surgery to suitably trained qualified and regulated Health Care Professionals only. This decision was reviewed by the JCCP Board of Trustees in September, 2024 when it was determined that such a restriction should continue to be enforced until the Government determines new standards for the award of a Practitioner Licence/Regulation for aesthetic practice in England and Scotland in 2026/2027. This remains the accepted policy position by the Council.

The Council has remained actively engaged throughout the year with beauty industry representative groups with the aim of promoting excellence in practice, education and training for the beauty sector. The JCCP meets regularly with representatives from The British Beauty Council, BABTAC and Habia.

The JCCP has also continued to meet regularly with the British Beauty Council (and its affiliate members) and with the Chartered Institute for Environmental Health (CIEH) to discuss, agree and share opinion and advice with the aim of coauthoring and developing a range of position papers as part of an ongoing policy development exercise that has been designed to inform and influence the Government’s proposed licensing scheme for the non-surgical cosmetic sector in England and Scotland. This work has focussed on a wide range of cosmetic procedures themselves as well as premises from which such procedures are practised and the products, devices, machines and medicines used in their transaction.

The Practitioner Register Committee has also agreed customised entry

2025/26 JCCP Annual Report

routes/application procedures for BCAM and GMC Plastics and Dermatology specialist professional colleagues and a significant number of successful applications have been made through this route.

The JCCP signed a renewed three-year Contract with Hamilton Fraser Resolution in April 2025 for the ongoing administration, delivery and maintenance of the JCCP Practitioner Register.

The JCCP Education and Training Committee has also met regularly throughout the year under the Chairmanship of Professor Mary Lovegrove and has continued to provide oversight and governance for the JCCP ‘Competency Framework’ and ‘Standards for Education and Training’ provider organisations, exercising its role as ‘gatekeeper’ of the JCCP and CPSA competency standards. The Education and Training Committee continues to receive applications from Ofqual regulated Awarding Organizations and UK University education and training provider training organisations who seek to apply to enter the JCCP Register of Approved Education and Training Providers/Approved Qualifications. The JCCP Education and Training Committee has provided oversight for the audit and approval processes relating to the same.

Throughout 2025 the JCCP has again witnessed a rise in enquiries from education and training providers who are seeking approval from the JCCP for their qualifications and education and training provision.

The JCCP continues to approve the University of Manchester, University of South Wales, Cosmetic Courses and the Harley Academy, Interface Aesthetics, Acquisition Aesthetics and the National Aesthetics Training Academy (NATA) to deliver VTCT approved ‘Level 7 Diploma in Clinical Aesthetic Injectable Treatments’ courses and MAP-IQ to deliver an ‘RPL route for the VTCT approved qualification ‘Level 7 Diploma in Clinical Aesthetic Injectable Treatments’. The Derma Institute was also approved in 2025 to deliver the OTHM/Derma Institute Level 7 Diploma in Clinical Aesthetic Injectable Therapies. An RPL route for the VTCT approved qualification ‘Level 7 Diploma in Clinical Aesthetic Injectable Treatments’ has also been approved by the JCCP for delivery by Cosmetic Courses and by the Harley Academy.

The Education and Training Committee made a decision to discontinue its ‘Fast Track’ scheme for practitioner registration. This decision will be reviewed in accordance with future policy requirements that form part of any future national scheme of licensing and regulation for the aesthetics sector in the UK.

2025/26 JCCP Annual Report

The Education and Training Committee also recognises the GMC Plastic Surgery and the Dermatology Specialist Register qualifications as alternative routes to being benchmarked against the JCCP Competency Framework with the result that ‘equivalence’ has been formally approved between these two educational frameworks. In addition, the JCCP continues to engage with the British College of Aesthetic Medicine (BCAM) to formally approve and endorse the BCAM Knowledge/Theoretical and Practical examination components of their Membership Examination and associated Grandparenting Scheme. The JCCP’s Education and Training Committee also reviewed and mapped the British Association of Medical Aesthetic Nurses (BAMAN) Education and Training Competency Framework (2025) against the JCCP/CPSA Education and Training Competency Framework (2018) and confirmed that it was fully compliant with the same,

The JCCP worked in partnership with the British Association of Aesthetic Medicine (BCAM) during 2025 to make recommendations on future education and training standards and qualifications for non-surgical cosmetic practice and made proposals on how aesthetic practitioners should be prepared to evidence their compliance with forthcoming DHSC/Scottish Government Regulation/Licensing standards (relating to requisite knowledge, practical competence and professional behaviours). Recommendations included the need to consider a scheme of credentialling for experienced and appropriately regulated healthcare practitioners part of any future licensing or regulatory scheme for the sector. The submitted paper proposed a range of routes to qualification, and potential ‘alternative’ routes (for regulated experienced practitioners) to demonstrate compliance with the new DHSC/Scottish Government industry standards (when they are produced) and proposed a series of ‘principles and recommendations’ for the Government to consider going forward (with particular regard to including a new credentialing route for suitably experienced regulated healthcare practitioners).

The JCCP Education and Training Committee also further revised its guidelines on CPD and considered how best to make proposals to oversee and ‘accredit’ CPD activities delivered by various and diverse training providers in the UK.

The JCCP Education and Training Committee has also hosted three webinars throughout the year relating to on education and training and on matters pertaining to the Government’s forthcoming aesthetics licensing scheme in England.

The JCCP team also met regularly with senior representatives from Ofqual and the

2025/26 JCCP Annual Report

SQA throughout 2025. Meetings were also held with IFATE/Skills England to inform the development of Level 6 and 7 Apprenticeship standards for implementation within the aesthetics sector.

The JCCP Executive Chair and Registrar engaged in bi-monthly meetings throughout the reporting year with representatives from the College of General Dentistry to discuss proposals for the design of a new credentialing route for dentists working in the facial aesthetics sector.

Two of the JCCP Trustees continue act as ‘Technical Experts’ for UKAS, enabling the introduction of UKAS accredited ‘certification of persons’ at the lower levels of practice.

The JCCP Marketing and Communications Committee has also continued to make excellent progress again this year and continues to function actively under the active chairmanship of John Underwood, JCCP Trustee, supported by Paul Burgess and Zoe Cooper. The Committee continues to raise public awareness about the Council’s mission, values, register(s) and public protection, in support of the UK Government’s declared commitment to enhance public awareness about the risks associated with some of the more invasive procedure practised within the sector. A key focus of the Committee’s work has been to review and promote activities undertaken by the JCCP’s political campaigns (such as those associated with the JCCP’s engagement with the UK and Scottish Government’s Regulation/Licensing Scheme) in association with the JCCP’s Key Opinion Leaders and sector ‘Influencers’ and partner associations regarding debates and publications relating to the potential implementation of the long-awaited national system of regulation and licensing for the aesthetics sector in England and Scotland.

The Committee was reviewed and relaunched in the Autumn of and has met regularly throughout the year and continues to be supported by a range of expert Key Opinion Leaders to promote the work and image of the Council. New Key opinion Leaders appointed in 2025 include Dr. Bob Kanna, Dr. Alison Colville and Jen Vittanuova.

The Committee also led on the enhancement and population of the JCCP’s main website and has commenced work on a refresh of the JCCP & me public facing website.

The Marketing and Communications Committee has provided a forum for national discussion and debate regarding patient safety and public protection which also served to promote the work of the JCCP during 2025/26. Engagement at all major

2025/26 JCCP Annual Report

national conferences and industry trade shows provided the opportunity to further disseminate the JCCP’s ‘Narrative’. Members of the JCCP Board of Trustees attended multiple face-to-face events during 2025. The JCCP has also continued to rely purposefully on the use of social media to disseminate key messages to members of the public and to practitioners. Responsibility for the JCCP’s social media portfolio transferred to the JCCP’s in-house team in 2025. Excellent relationships have also been maintained and developed further with both the professional and aesthetic press/media sector, supported by the publication of regular articles and papers and conference presentations, including the provision of regular articles to Journal of Aesthetic Nursing. The JCCP has also continued to liaise and collaborate with other media fora to raise public and practitioner awareness of our shared mission to improve public protection and patient safety. Throughout the reporting year a range of purposeful and well received webinars have been transacted in support of the JCCP’s public protection and patient safety mission. These webinars have been spearheaded by Zoe Cooper, JCCP Project Development Officer as part of a new series of public facing promotional activities, transacted in association with designated JCCP Key Opinion Leaders.

Zoe Cooper, the JCCP Project Development Officer, has assumed responsibility for the production and publication of monthly articles throughout the course of the reporting year. JCCP Trustee, Kimberley Cairns has also produced a range of articles that focus on psychosocial and emotional wellbeing and importance of embedded these principes within all aspects of aesthetic practice. Julie Scott (JCCP KOL) has also published a series of articles relating to safe and expected prescribing practice and a further article relating to patient safety risks associated with the use of unregulated toxins (and their association with botulism toxicity). Dr. Patrick Treacy (KOL) published an article on ‘The Future Thread Lifts’ whilst the JCCP team publishes a range of articles relating to the Westminster and Scottish Government’s proposals for regulation and licensing. Other published features related to teeth whitening, weight loss injections and the NMS’s ruling on face-toface prescribing.

The Marketing and Communications Committee also spearheaded a most successful campaign to ensure that the UK Government acted in a timely manner to enact the long awaited DHSC proposed licensing scheme for England. This campaign included the publication of public and stakeholder facing online briefing documents. The Committee has also actively promoted the Scottish Government’s 2024/25 consultation on non-surgical cosmetic licensing and regulation and the ensuing Bill entitled ‘Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Bill (SP Bill 77)’.

2025/26 JCCP Annual Report

The JCCP was a Category Winner at the March 2025 Aesthetics Awards Ceremony for the Best Initiative/Strategic Project in Aesthetics. This award recognises the incredible work undertaken by the JCCP complaints team to raise standards in the aesthetics industry, with a particular focus on improving patient safety and transparency.

David Sines, Executive Chair and Registrar of the JCCP and fellow Trustees have been the subject of several national TV and radio media broadcasts throughout the year regarding safe and effective practice, regulation and licensing updates and public protection.

The JCCP’s Corporate Membership Scheme has thrived again this year, enhancing the JCCP’s capability and capacity to raise charitable funds with the aim of enhancing public protection and patient-safety-related activities within the aesthetics sector. In excess of £120,000 has been raised this year through donations and the corporate member fundraising scheme which has enabled the JCCP to further its activities with regard to the promotion of patient safety and public protection (including the construction of a new patient/consumer facing website).

The Council continues to work with other corporate partners to promote best practice in the manufacture, supply and use of medicines and products with the aim of enhancing health protection, infection control, medicines optimisation and patient safety. Corporate partners are represented within the JCCP as members of the Clinical Advisory Group (CAG) and the Trustee Board.

The JCCP continues to transact a very active and productive partnership with the Aesthetic Complications Expert Group World (ACE). The partnership functions with the aim of enabling the JCCP and ACE to work together to promote best practice and standards in the aesthetic industry in furtherance of a shared commitment to public protection and consumer safety/awareness. This partnership has continued throughout 2025 and had been renewed for a further there year period. This partnership provides mutual benefits for registrants and members by supporting them to raise and share issues of concern regarding activities of aesthetic practitioners, where client/patient safety/public protection has been considered to have been compromised and to encourage aesthetic practitioners to engage in reflection and continuous professional development in order to further develop and improve their practice.

Positive working relationships have also been maintained and transacted with the British Association of Medical Aesthetic Nurses (BAMAN) with particular regard to

2025/26 JCCP Annual Report

the promotion of patient safety and public protection, education and training standards and prescribing practice standards. The JCCP reviewed its corporate membership policy and eligibility criteria during 2025 to ensure that key issues relating to eligibility and potential ‘conflicts of interest’ are overtly addressed. The JCCP Oversight/Scrutiny Committee will now review new applications and address any potential identified ‘conflicts of interest’. The final decision on joining the JCCP corporate membership scheme will be made by the Oversight/Scrutiny Committee. It was agreed that Education and training providers seeking JCCP ‘approval’ will be separately managed under the JCCP Education and Training Committee.

With regard to fiscal and constitutional compliance the JCCP once again remains recurrently ‘solvent’ and has been able to attract charitable support from a range of benefactors who have again this year offered their services (without charge) to enable the Council to maintain its operational functions. During 2025 the JCCP was able to return a healthy surplus.

The JCCP Board Trustees are fully cited on these matters and share the responsibility of assuring the PSA of the diligent and prudent approach that the JCCP has taken with regard to managing and implementing its fiscal processes and quality assurance requirements relating to the maintenance and publication of a Registrant database and in the transaction of its responsibilities to members of the public and to stakeholders.

Two patient advocate representatives are appointed to the JCCP Trustee Board as full voting Trustees, supported by six other lay Trustees and seven Practitioner/Sector Stakeholder Trustees/Members.

The JCCP and CPSA hosted two virtual Stakeholder Council meetings during 2025, Chaired independently by Dr. Tamara Griffiths, President of the British Association of Dermatologists. The Stakeholder Council provides a conduit of engagement with the JCCP Trustees and with the Council and its sub-committees. The key themes for these stakeholder events related to patient safety, public protection, raising public awareness and messaging regarding safety in the aesthetics sector and an update on proposals for the implementation of a national system of regulation licensing for the aesthetic sector in England and Scotland.

The JCCP has also continued to maintain an excellent working relationship with the CPSA, underpinned by a robust Memorandum of Understanding and reciprocal Board membership. Throughout 2025 the JCCP and CPSA continued to meet regularly and to review, promote, implement and disseminate their shared

2025/26 JCCP Annual Report

Code of Conduct and clinical practice standards. This document may be accessed via the JCCP website.

The key focus of the JCCP’s engagement with the CPSA this year has been to consider invasive BBL and liposuction-related procedures, IV infusion related procedures, non-surgical laser and light procedures and emergent non-surgical procedures and to prepare new clinical to inform the Government’s licencing/regulatory schemes for England and Scotland.

The JCCP has fully complied with its published Policy Statements on Complaints (2023), Equality, Diversity, and Inclusivity (November, 2021) Safeguarding (November, 2021) and Boundary Setting (2023), Statement on Bullying, Undermining and Harassment Guidance (2023), ‘Raising Issues of Concern (Whistleblowing) Policy (2023). The JCCP confirms that it has reaffirmed its operating Reserves policy with £100, 000 held back in reserve and that all other policies, procedures, and governance arrangements remain fit for purpose. All policies and procedures have been shared routinely with the PSA. The JCCP also confirms that it possesses appropriate insurance and employer liability cover and remains in good financial and corporate governance standing with both the Charity Commission and with Company’s House.

The JCCP received notification of an official complaint in June, 2025 submitted by the ‘Independent Aesthetics Practitioners Register (IAP)’ in the form of an extensive ‘dossier’ of issues relating to the JCCP’s governance systems, decision making powers and scope of policy-related influence. The JCCP convened a meeting of the Board of Trustees to consider this ‘dossier’ in detail in July, 2025. In August 2025 The Charity Commission for England and Wales advised the JCCP ‘In this case, we have decided that providing advice and guidance to the trustees is the proportionate step at this time’. No findings were found against the JCCP regarding this complaint. The JCCP Board considered the Charity Commission’s response at their Board meeting in September, 2025 and considered advice provided by the Commission regarding expected standards of governance and the management of conflicts of interest. The Board of Trustees noted this advice and confirmed that they were compliant with the same. No notification or expression of concern regarding this complaint was received by the JCCP from the PSA.

The JCCP Board of Trustees confirms that there have been no legal or constitutional challenges to the work of the JCCP or to its published governance arrangements/procedures. Relationships with external bodies have been excellent, encouraging, supportive and most productive. All Memoranda with Professional Regulators remain valid and where applicable all have been renewed during 2025.

2025/26 JCCP Annual Report

The JCCP’s Continued Contribution to the Regulation and Licensing of Cosmetic Procedures in England and Scotland

2025/26 JCCP Annual Report

The JCCP has continued to devote significant time to inform and support the full implementation of a new system of governance, supported by robust practice, premises and education and training standards for the aesthetic sector within the four countries of the UK again this year.

Throughout the year the JCCP maintained active liaison and engagement with both the Westminster and Edinburgh government department teams responsible for regulation and licensing in the aesthetic sector. The JCCP remains firmly committed to the enactment of all of the key proposals included in the DHSC/Scottish Government consultation document (September, 2023 and December 2024). As an eclectic stakeholder organisation, the JCCP relies upon consultation with multiple representative membership groups, regulators, the pharma and insurance industries and of course with members of the public.

In November, 2025 the JCCP was invited by the DHSC (along with other key stakeholders) to join a task and finish group to assist in the design of a new scheme of regulation for ‘red procedures’. The key aim of this group had been defined as informing ‘Restrictions on high-risk cosmetic procedures’ and to ‘Agree which treatments, beyond the liquid BBL, carry sufficient risk that they should be restricted to healthcare professionals only and should be included within the scope of CQC registration; to agree whether age restrictions should apply to the relevant treatments’ and to ‘refine the criteria for which health care professionals are permitted to perform the restricted treatments’. The JCCP has been actively engaged as a member of this task and finish group.

In association with BCAM the JCCP has produced three papers that have been submitted to the DHSC and to the Scottish Government to inform the future, shape and nature of licensing and regulation for aesthetic procedures in both England and Scotland.

The JCCP has also responded to a range of alarming reports throughout the year associated with the use of illegal toxin imports and the continued application of invasive procedures being performed inappropriately by unqualified persons. The JCCP has continued to be actively involved in seeking the introduction of urgent government regulation to restrict procedures such as Brazilian Butt Lifts (BBL) and others across the aesthetics sector. Alongside, the British Beauty Council (BBCo) and the Chartered Institute of Environmental Health (CIEH) the Joint Council for Cosmetic Practitioners (JCCP), has called upon the UK Government and devolved nations to introduce emergency legislation to ensure that invasive procedures, such as liposuction and BBL are performed only by appropriately qualified General Medical Council (GMC) registered doctors.

2025/26 JCCP Annual Report

The publication of the JCCP’s document entitled ‘Buttock Augmentation and other Body Contouring Procedures. - Guidance for Local Authority Environmental Enforcement Officers (authored by the Chair of the JCCP Clinical Advisory Group, Andrew Rankin in association with key professional stakeholders) has led to the successful prosecution of ‘illegal unqualified operators’.

It is in this context that the JCCP has support the UK and Scottish Governments’ proposals to apply a sequential approach to a legally enforceable scheme of regulation, commencing with immediate legislation to restrict the ‘Red/Group 3) procedures referred above, (with the caveat that the Government remains committed to ensuring that any such scheme of licensing is legally implemented and enforced as soon as possible to cover all procedures included in the Government’s final determination of ‘green’, ‘Amber’ and ‘Red cosmetic interventions).

More specifically we have also continued to advise the UK Government that they should urgently prepare and publish a statement outlining the Government’s commitment to publishing the full response to their September 2023 consultation and a date advising when this will be published.

The JCCP has reiterated its request to the UK and Scottish Governments that it will honour its previously declared intention to work with expert groups on the elements that will underpin the licensing scheme, including education and training standards, insurance, infection control and hygiene qualifications and a fees model.

The JCCP also remains firm in its position that the responsible Government Departments in all four UK nations should be required to acknowledge and commit to the formulation and implementation of a four-nation mandated minimum education and training standard as a core component of any future scheme of regulation/licencing. The JCCP believes that this is essential to ensure patient safety and thus should be a central pillar of a future licensing regime. We have advised that the Joint Council of Cosmetic Practitioners in partnership with the Cosmetic Practice Standards Authority (CPSA) has already developed a competency framework covering high-risk non-surgical cosmetic procedures. The JCCP and the CPSA look forward to contributing to this agenda discussion.

The JCCP has also been working apace with the Government and with the Advertising Standards Authority (ASA) to introduce more robust and assertive regulation on advertising and social media. During the reporting year the Government and the MHRA has outlined plans to strengthen medical devices

2025/26 JCCP Annual Report

regulation, including extending UKCA mark recognition as part of transitioning to a future regime and the scope of regulations to capture certain non-medical products with similar risk profiles to medical devices – this includes dermal fillers. The JCCP has advised that as an additional public protection measure that advertisements (across all media channels) should ‘include the requirement to display a kitemark and a warning logo on any advertisement for treatments that fall within the licensing regime’s scope’.

David Sines, Executive Chair and Registrar of the JCCP provided oral evidence to the Parliamentary Women’s and Equality Committee in June, 2025 regarding ‘The cost of delay on licensing and regulation of non-surgical cosmetic procedures’. Andrew Rankin, Trustee also provided oral evidence the All Party Parliamentary Group on Beauty and Wellbeing in July, 2025.

Central to our response to UK and Scottish Government departments regarding future regulation and licensing has been our advice that the two Government departments should undertake to ensure that all procedures that involve the use of a prescription only medicine that is part of the actual procedural application, as an adjunctive requirement, such as the use of Lidocaine or Adrenaline, or any procedure that could involve the use of a prescription only medicine to manage an urgent complication arising from an aesthetic procedure should be supervised by a professionally, regulated prescriber who is present on site when the procedure itself is conducted. Should this not be agreed then we advised that any such procedure should be moved to the Government’s proposed ‘Red’ category in the interests of public protection and patient safety.

We have also advised UK Government Departments that we consider it necessary to define what is meant by ‘supervision’ and ‘oversight’, and also to determine who could be considered to be an appropriate supervisor for specific procedures. We stated that the concept of supervision would need to be determined in accordance with a risk assessment undertaken for each of the procedures that are determined to be included in national licensing/regulatory regimes on a procedure - by - procedure basis. The JCCP considers that a proportionate approach to the definition of supervision should be taken on the basis of risk to members of the public related to the level of complexity, invasiveness and the potential for complication that the procedure itself might present or where there is consistent evidence of abuse of or lack of compliance with current regulations.

The JCCP will continue to call for other additional measures to supplement the proposed licensing system:

2025/26 JCCP Annual Report

• The need for extended powers to be given to the CQC/HIS to inspect all premises where invasive procedures that are included in the license are to be performed.

• To seek an assurance that the CQC/HIS will develop a memorandum of understanding with local authority licensing organisations to perform an integrated and enhanced scheme of regulation for aesthetics to avoid duplication for those healthcare professionals who are already registered with the CQC/HIS.

• To call for the implementation of a UK wide register of approved qualifications and of approved education and training providers in all four countries of the UK.

• To consider whether the PSA could be given extended powers to oversee registers of approved education and training providers and qualifications in the sector in addition to their current statutory function of overseeing practitioner registers.

• Ofqual/SQA to be requested to ensure that they only approve qualifications in the future that meet the new Government standard for education and training for the aesthetics sector.

• National, mandatory education and training standards to be introduced for all practitioners who practise in the industry. This should be the subject of a fournation wide approach mandated for implementation in England, Scotland, Wales and Northern Ireland.

• The legal enforcement of the requirement for all practitioners to have an appropriate level of medical indemnity insurance and to provide a transparent redress scheme for service users.

• National scrutiny and action to prevent the promotion through social media of unsafe, unethical and exaggerated messaging about products, education, training and aesthetic service provision.

The JCCP is also aware that a range of potentially harmful and unlicensed ‘products’ and devices that continue to be supplied and administered as part of a number of cosmetic procedures. The JCCP is reviewing many of these devices, ‘machines’ and products and is advising the MHRA of the need to introduce rigorous controls regarding the importing, manufacture and supply of such products and devices. Where it is determined by the MHRA that these products are not medicines or medical devices, the JCCP will continue to call for review of the regulations that apply, and their enforcement by Trading Standards Officers.

In Wales new arrangements for mandatory licensing of tattooing, skin piercing, acupuncture and electrolysis are being put into place. Under the Public Health (Wales) Act 2017 the Welsh Government may add procedures to these

2025/26 JCCP Annual Report

arrangements but have not announced any intention to do so at this time. The JCCP has been actively engaged with the Welsh Government at all stages of the formulation, consultation and enactment of this new policy change.

The Northern Irish Executive has not announced any current plans to introduce regulation in the non-surgical cosmetic sector. The JCCP however been in active discussion with environmental health colleagues in Northern Ireland to share and promote best practice to enhance patient safety and public protection.

2025/26 JCCP Annual Report

Advertising and Social Media Our Work with the Advertising Standards Authority

2025/26 JCCP Annual Report

Throughput the reporting year the JCCP has again witnessed multiple examples of exaggerated, untruthful and false advertisements that are posted on social media. We are also continuing to see gross misrepresentation of the benefits of treatment, understatement of the risks and exaggerated and false claims relating to the provision of education and training. The JCCP has therefore worked very closely with the Advertising Standards Authority and contributed to the development Government’s ‘Online Safety Act, 2023’ to seek to reduce the number of inaccurate, exaggerated and potentially harmful advertisements on social media postings regarding nonsurgical cosmetic procedures and the posting of advertisements that offer education and training to practitioners that do not meet the standards required to equip practitioners with the educational knowledge and competencies to enable to practise safely and proficiently.

The JCCP has transacted an excellent partnership with the Advertising Standards Authority to share reports relating tounacceptable and illegal forms of advertising. The ASA continues to respond on a regular basis to complaints raised by the JCCP by publishing many new rulings that will affect both registered healthcare practitioners working in aesthetic practice and lay practitioners.

The JCCP has also continued to identify and report those education and training providers who profess to offer qualifications and training programmes that do not reflect the standards to deliver safe and competent aesthetic treatments. This has been the subject of a key JCCP campaign working alongside the Advertising Standards Authority (ASA) to respond to inaccurately or exaggerated claims promoted and advertised by some unregulated education and training organisations.

JCCP Clinical Advisory Group Activities

The JCCP’ Clinical Advisory Group (CAG) has continued to meet throughout the year in a bi-monthly basis under the joint Chairmanship of Andrew Rankin and Dr. Paul Charlson. The key aim of the CAG has been to work alongside the CPSA to inform, adopt and promote practice standards for the non-surgical and hair restoration sector. The CAG has also provided a forum to support clinical leadership, advice, scrutiny, and challenge with regard to clinical practice related matters to the JCCP Trust Board. In particular the CAG has again:

• Championed clinical excellence for patients and members of the public. Advised on clinically related professional healthcare aspects of operating the JCCP Registers.

• Provided clinical advice and oversight in relation to JCCP policies and activities.

2025/26 JCCP Annual Report

• Provided an overarching forum to co-ordinate discussion and to formulate opinion on matters relating to the use, supply and administration of safer products/medicines, the provision of standards and systems of inspection for safer premises and safe working practices.

• Assisted the JCCP in the formulation of any new policies that require a clinical input and focus.

• Raised and responded to major issues of clinical concern on operational performance within the cosmetic sector.

• Advised on and supported the development of solutions to current and emergent clinical issues.

• Advised on compliance requirements relating to legal, policy and regulatory frameworks of practice within the four countries of the UK.

• Responded to and advised on clinically related enquiries from the media, government agencies, members of the general public or practitioners. Provided ongoing advice to both the MHRA and to the CQC on key issues relating to aesthetic practice and future regulation.

• Led on the formulation of updated and new guidance to inform the DHSC and Scottish proposals for licensing and regulation relating to procedures to be included in the scope of the new Practitioner scheme of regulation and licensing.

• Developed guidelines on ‘supervision’, ‘oversight’ and ‘what constitutes an appropriate professional’.

• Advised on matters relating to the holding of stock medication and remote prescribing.

• Formulated guidelines on a range of specific clinical procedures, including Plasma Replacement Therapy (PRP).

The Clinical Advisory Group (CAG) includes engagement with the CQC, the MHRA, the British Beauty Council, BABTAC, Habia, The Chartered Institute for Environmental Health, Regulators, Global and National Pharma and Pharmacy companies and other key stakeholders to consider and advise on matters that pertain to the design of a licensing scheme for the aesthetics sector in England. Whilst this group has no regulatory intent or remit it has developed strong relationships with regulators and with stakeholders, providing the opportunity for eclectic debate and discussion to inform future deliberations and direction on this subject. The Clinical Advisory Group continues to work on the messaging required to ensure the appropriate and ethical supply of medicines, products, devices and machines. It is the JCCP’s belief that members of the public should have access to the knowledge required to confirm that they are receiving safe and regulated products from designated and approved suppliers.

2025/26 JCCP Annual Report

Once again, this year the JCCP has worked with several Professional Statutory Regulators (the General Medical Council, the General Dental Council, the Nursing and Midwifery Council, the General Pharmaceutical Council and the Royal Pharmaceutical Society) to seek their uniform endorsement of the JCCP and CPSA’s decision not to endorse or permit the remote prescribing of any prescription medicine when used specifically for non-surgical cosmetic treatments. In May 2025 the NMC announced that it would not permit any of its independent prescribers to prescribe any prescription only medicine for cosmetic purposes without first requiring the prescriber to undertake a face-to-face holistic assessment of the patient. The JCCP was instrumental in achieving this outcome.

The JCCP remains firm in its position on this matter and has engaged with all relevant responsible (PSRBs) to promote its guidance statement on ‘Responsible Prescribing for Cosmetic Procedures’ (September, 2022). (The guidance can be found on the JCCP website).

In November, 2025 Andrew Rankin, Chair of the JCCP Clinical Advisory Group was invited to join a working group designed by the NMC to review their ‘Code’ with specific reference to advising on cosmetic prescribing.

CAG also enjoys an excellent collaborative partnership with colleagues at the CQC and representatives from the JCCP meet regularly with CQC officers to discuss clinical and regulatory matters relating to the cosmetic sector.

The JCCP’s Memorandum of Understanding with the MHRA was renewed again in 2025 and is transacted through the MHRA’s active membership of CAG. The JCCP’s Key Opinion Leaders are also invited members of the JCCP’s Clinical Advisory Group. CAG also enjoys an excellent collaborative partnership with colleagues at the CQC.

The JCCP is continues to work with the CPSA to identify a range of emergent treatment modalities/procedures which are regarded to have a proportionate degree of risk associated with their transaction (e.g., Platelet Rich Plasma procedures, IV infusions and laser and light procedures). The CPSA and the JCCP is now actively developing new clinical practice standards for these procedures in support of the proposed licensing/governance schemes proposed for both England and Scotland.

The JCCP has enjoyed an excellent working relationship again this year with the British Association of Medical Aesthetic Nurses (BAMAN) and with the British College of Aesthetic Medicine (BCAM) through the medium of a shared

2025/26 JCCP Annual Report

Memorandum of Understanding. The JCCP also welcomed Dr. Elaine Sassoon as a newly appointed Trustee to the JCCP Board as an official representative of BAAPS (The British Association of Aesthetic Plastic Surgeons’. The Royal College of Surgeons has also been engaged as a most valued and active partner throughout the year, supporting the JCCP in drafting guidance on both non-surgical and cosmetic surgical procedure. This alliance has continued throughout 2025 as part of our shared commitment to co-designing new standards to inform national schemes of licensing and governance for the sector in England and Scotland.

The JCCP’s partnership with the Royal College of Public Health (RSPH) has also continued throughout the year with an emphasis on health protection and infection control standards and online training.

The JCCP recognises that there are major issues associated with the lack of data and substantive research relating to the cosmetic sector. There are many small studies available but there is no coordinated national framework to collect data on the sector or to develop a considered evidence based research programme. The JCCP has again commissioned research programmes this year in key areas relating to patient safety which have been supported by its corporate partners. The JCCP recognises that our research programmes require further investment and scaling up if we are to contribute meaningfully to provide substantive evidence to practitioners, stakeholders, and government to influence policy change. The reason for this is clear. The non-surgical cosmetic sector has grown rapidly and is a sector where new treatments are emerging exponentially. The JCCP is well positioned to act as a coordinating or overarching body to review and consider emergent research needs and trends within the aesthetics sector and as a charity the Council is able receive grants and funds in furtherance of public protection and patient safety aims. It is therefore proposed that this is an area that can be further developed in 2025/2026 in partnership with our corporate members and stakeholders.

The JCCP CAG also published guidelines for the reporting of adverse incidents. This guidance statement acts as a reminder to all regulated healthcare cosmetic practitioners of their professional obligations in reporting adverse incidents. It also serves to highlight the ethical responsibility that unregulated practitioners have in doing the same. This statement concerns the reporting of both medicines and medical devices of all types that fall within the remit of the Medicines Healthcare products Regulatory Agency, and where facility is provided through its Yellow Card scheme to enable such reporting. The Statement may be viewed here. The JCCP considers that an improved data set of adverse incidents will inform the ongoing development of regulations within the sector (including the design of the new

2025/26 JCCP Annual Report

proposed licensing standards and framework). We therefore encourage all practitioners to review this paper and to follow the guidance it provides.

One other area of significant growth during 2025 has been the provision of multiple education and training events provided to various environmental health organisations and teams throughout the UK. Regular seminars, webinars, training events and engagement sessions have been transacted in association with Colleagues from the Chartered Institute for Environmental Health. Participation has exceeded in excess of 400 environmental health officers during 2025, which pays testimony to the key interest demonstrated by these professional colleagues as the implementation of a new system of regulation and licensing for cosmetic in England and Scotland progresses.

These events arose from the JCCP’s ongoing commitment to supporting individual local authority environmental health officers/teams who wish to understand, or investigate, cosmetic surgical and non-surgical activity/procedures undertaken in their area. The practice of cosmetic surgical and non-surgical procedures is the focus of continued growth as the sector moves towards regulation. The JCCP has now become embedded as a trusted source of advice and guidance for local authority environmental health officers in all four countries of the United Kingdom.

The JCCP also continues to engage with the Institute of Licensing to support public safety through licensing.

2025/26 JCCP Annual Report

Promoting Positive And Informed Psychological And Emotional Health

2025/26 JCCP Annual Report

The JCCP has continued to work actively to promote positive and effective messaging to consumers and practitioners, including responsible marketing and the appropriate and ‘safe’ use of social media/Apps that support and promote positive mental health and wellbeing. JCCP Trustees Dawn Knight and Kimberley Cairns have also continued to work closely with a range of mental health agencies to enhance psychological and emotional well-being for members of the public who seek to receive aesthetic treatments. Key areas of activity this year include the provision of advice to MPs, Civil Servants, Regulators and to the ASA on matters relating to social media and the such as the implementation of the ‘Online Safety Act’, 2023. The JCCP also benefitted significantly this year through the publication of articles and guidance documents relating to body image and emotional resilience etc. produced by Kimberley Cairns (JCCP Trustee). These documents have been published on our websites by Zoe Cooper, JCCP Project Development Officer.

Kimberley Cairns has also designed a new ‘Inclusive Consultation Framework for Psychologically Informed Safer Aesthetic Practice’ that relates to a commitment to publish a concise, accessible guidance resource—centred around a validated screening tool—to support psychologically attuned consultations and follow up appointments. A ‘The Mindful Aesthetic Project’ is also being designed by Kimberley Cairns and JCCP Project Development Officer, Zoe Cooper to maximise the impact of this work.

2025/26 JCCP Annual Report

Complaints Reporting 2025/26 JCCPAnnual Report

This reporting year has once again witnessed multiple complaints being reported via the JCCP on lone complaints portal. Unfortunately, as in previous years (as is often the case when systems and processes are challenged) the JCCP has received multiple complaints regarding non-JCCP Registrants regarding practice related issues and from members of the public/practitioners regarding exaggerated or misleading claims about the quality, standard or advertising of education and training courses. The JCCP has taken each complaint seriously and has undertaken to contact each Complainant and where appropriate to refer them on to other relevant organisations in order to seek resolution. The JCCP Trustee Board has received regular ‘complaints’ summary/reports for discussion and consideration. The complaints process and related activity has been most competently coordinated and led by JCCP Trustee Sally Taber in association with Dawn Knight (Patient Trustee), ably supported by the JCCP’s Project Development Officer, Zoe Cooper.

A new digitally informed complaints portal was designed in the Autumn of 2025 and will be piloted in early 2026 with the aim of improvising and enhancing the effectiveness and productivity of the JCCP’s complaints systems.

The JCCP has published an information document entitled ‘Bringing your Complaint to us’ to advise members of the public on when and how to raise a complaint to the Council.

2025/26 JCCP Annual Report

.¥ Other Significant Achievéments 2025/26 JCCPAnnual Report

The JCCP has continued to work very closely with five Professional Statutory Regulatory Bodies (PSRBs) this year:

• The GMC (The General Medical Council)

• The GDC (The General Dental Council)

• The NMC (The Nursing and Midwifery Council) The GPhC (The General Pharmaceutical Council) The HCPC (The Health Care Professions Council)

Memoranda of Understanding remain current between the JCCP and these professional statutory regulators who together recognise the importance of joint working to ensure public protection and patient safety. These agreements continue to seek to ensure that effective channels of communication and information sharing are established and maintained between the named PSRB and the JCCP to promote patient safety and high quality services for patients receiving aesthetic treatments and where appropriate and necessary, the processes and procedures adopted by the JCCP and the PSRB, with regard to matters of ‘fitness to practise’ for registered clinicians involved in the provision of aesthetic treatments. In addition, the ‘Memoranda’ relate to the areas of interface between the named PSRB and the JCCP and clarify respective roles and responsibilities and outline mechanisms in place to promote effective liaison. A formal exchange of letters has also established a firm working relationship with the HCPC. Regular meetings continue to take place with the GMC, the GDC and the NMC.

The JCCP/CPSA Code of Practice (2023) continues to be applied throughout the Council’s work and assumes that any practitioner who undertakes cosmetic treatments is embarking on a new career pathway, associated with significant risk of harm to patients and members of the public. The JCCP therefore applies and promotes the use of a range of fitness to practice procedures that are designed to promote best practice within the sector and to set out guidelines appropriate to all levels of practitioner as to the risks involved and how to mitigate them, alongside the implementation of sanctions if required. These procedures apply to all JCCP registered aesthetic practitioners, regardless of level of attainment or professional background. These procedures (and their associated sanctions) apply equally therefore to those cosmetic practitioners who are registered clinicians and to those who do not have registerable status with a Professional Statutory Regulatory Body (PSRB) and who perform procedures that the JCCP formally recognises and for which the JCCP and CPSA have set standards for. Our aim continues to provide a practitioner with a sense of belonging to this applied area of practice and to

2025/26 JCCP Annual Report

outline the duty of care that they should provide to the public and to other practitioners.

The JCCP Practitioner Register Committee published two Practitioner Newsletters during2025 in which Registrants (and members of the public) were provided with details of the JCCP Practitioner Register annual renewal process and sampling requirements and were updated regarding the JCCP’s developments and related political activity.

2025/26 JCCP Annual Report

Ot er Notable Matters 2025126 JCCPAnnual Report

The JCCP has also continued to work collaboratively with the Care Quality Commission (CQC) and the ‘MHRA’ this year regarding the provision of safe treatments, premises regulation, product and device standards and prescribing regulations. The overarching objective of these discussions continues to facilitate discussion and the establishment of common ground for the formation of understanding between relevant authorities – the ‘MHRA’, the CQC and CPSA/JCCP. The JCCP transacts an established and respected working relationship with Ofqual, the CQC and ‘MHRA’, sharing a common interest educational governance and in ‘patient and product safety’. Regular bi-monthly virtual meetings have been held again this year with all three organisations, complemented by a regular exchange of correspondence and attendance at JCCP Committee meetings.

The JCCP Chair and other Trustees also attended regular meetings with representatives of the House of Commons and the House of Lords during 2025 to discuss cosmetic regulation and to reinforce the case for statutory regulation for the sector, with particular regard to mandating a minimum standard of educational competence for all practitioners who deliver invasive treatments in the sector. Active liaison with Parliamentarians from both the House of Commons and the House of Lords continues. The JCCP’s facilitation and engagement with key Government representatives, MPs and with regulatory agencies continues to provide evidence of the Council’s transaction of its core mission – public protection and patient safety.

The JCCP has also engaged regularly with other key sector stakeholders. For example, meetings have been held throughout the year with insurers and indemnifiers, pharma and product manufacturers and pharmaceutical suppliers and with education and training provider organisations. As a result of such engagement the JCCP has appointed representatives from the Insurance sector, Pharma companies and Pharmacy distributors to its Committees and to its Trustee Board.

Key Priorities For 2026:

• The Council will continue to campaign for the full implementation of the JCCP 10 Point Plan as part of the UK and Scottish Government’s proposed licensing schemes.

• The JCCP will continue to be actively and fully engaged in influencing, shaping and implementing the UK and Scottish Government’s proposals for regulation and licensing in England and Scotland.

2025/26 JCCP Annual Report

• The JCCP will lobby for the design and implementation of a mandated UK 4 country-wide adoption of new clinical, education and training competencies to underpin the proposed regulation/licensing scheme for non-surgical cosmetics. The JCCP will continue to operate its PSA approved Practitioner Register under the same terms and conditions as currently used (free membership and agreed auditing arrangements with the Practitioner Register Committee and the PSA). The JCCP will further develop its Education & Training Register for providers and qualifications in association with DHSC/Scottish Government proposals for the design and implementation of a new regulation/licensing scheme in England and Scotland.

• The JCCP’s Clinical Advisory Group will continue to work with the CPSA and key partners to develop new and revised standards to assist in the design of a new and responsive model for licensing, and to identify emerging procedures that may warrant inclusion in the UK and Scottish Government’s new proposed licensing/regulatory systems.

• The JCCP will continue to engage with research partners to contribute to the evidence base to inform safe and effective aesthetics practice and governance. The JCCP will continue to build on those areas where it is seen as having a major strategic role in the sector – influencing members of the public, government, regulators and other stakeholders, complaints handling, standard setting, licensing and education and training.

• The Council will expand and develop the JCCP&me consumer/public facing website to further raise consumer awareness of risk associated with the higher level/invasive procedures.

• The Council will review, update and enhance its social media presence and identify innovative and responsive ways to promote the JCCP’s patient safety and public protection ‘message’ through its Marketing and Communication Committee strategy.

• The Council will continue to redesign, develop and promote its consumer complaints platform in the interests of public protection and patient safety. Priority will be given to grow and develop the JCCP Corporate Membership Scheme for commercial partners in the aesthetics sector.

• Consideration will be given to aligning the JCCP practitioner register with future licensing/regulations as they arise along with the implementation of charging policies.

• Consideration will be given to options for government funding for JCCP/CPSA, revised standard-setting, and competency framework updates.

Professor David Sines CBE PhD FRCN

Executive Chairperson and Registrar JCCP, February 1st 2026

2025/26 JCCP Annual Report

JCCP (limited by guarantee)

Independent Examiner's Report to the Trustees for the year ended 31 December 2025

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2025.

Responsibilities and basis of report

As the charity's trustees of the Company (who are also the directors of the company for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ("the 2006 Act").

Having satisfied myself that the accounts of the Company are not required to be audited for this year under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ("the 2011 Act"). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention which gives me cause to believe that:

1. accounting records were not kept in accordance with section 386 the Companies Act 2006 Act; or

2. the accounts do not accord with such records; or

3. the accounts do not comply with the relevant accounting requirements under section 396 of the Companies Act 2006 other than any requirement that the accounts give a "true and fair view" which is not a matter considered as part of an independent examination; or

4. the accounts have not been prepared in accordance with the Charities SORP (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

J Bardolph ACA, FCCA, BFP Independent examiner

Accountably Ltd 1st Floor, Unit 12 Compass Point Ensign Way Hamble Southampton Hampshire SO31 4RA

Dated: 21/05/2026

54

JCCP (limited by guarantee)

Statement of Financial Activities and Income and Expenditure Account for the year ended 31 December 2025

Notes INCOMING RESOURCES Incoming resources from generated funds Donations 2 Charitable activities 3 Investment income 4 Total incoming resources RESOURCES EXPENDED Charitable activities 5 Governance costs 6 Total resources expended Transfers between funds Net movement in funds RECONCILIATION OF FUNDS Total funds brought forward TOTAL FUNDS CARRIED FORWARD 9 NET (OUTGOING)/INCOMING RESOURCES and net (deficit)/surplus for the year	2025 Unrestricted fund Restricted fund Total funds £ £ £ 38,946 - 38,946 73,715 - 73,715 1,275 - 1,275 113,936 - 113,936 91,999 - 91,999 23,396 - 23,396 115,395 - 115,395 (1,459) - (1,459) - - - (1,459) - (1,459) 94,675 - 94,675 93,216 - 93,216	2024 Total funds £ 56,260 71,438 965 128,663 87,775 20,705 108,480 20,183 - 20,183 74,492 94,675

The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of total recognised gains and losses has not been prepared

All of the above amounts relate to continuing activities

The notes form part of these financial statements

55

JCCP (limited by guarantee) Balance Sheet as at 31 December 2025 Notes CURRENT ASSETS Debtors 7 Cash at bank CREDITORS Amounts falling due within one year 8 NET CURRENT ASSETS NET ASSETS FUNDS 9 Unrestricted funds: Restricted funds TOTAL FUNDS	2025 Total funds £ 13,577 115,514 129,091 (35,875) 93,216 93,216 93,216 - 93,216	2024 Total funds £ 6,253 125,106 131,359 (36,684) 94,675 94,675 94,675 - 94,675

The members are satisfied that the charitable company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.

The members have not required the charitable company to obtain an audit in accordance with section 476 of the Act.

The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has also been delivered to the Registrar of Companies.

The financial statements were approved by the Board of Trustees on 21/05/2026 and were signed on its behalf by:

………………………………… Prof D Sines CBE PhD FRCN Executive Chair of Management Board

The notes form part of these financial statements

56

JCCP (limited by guarantee) Notes to the Financial Statements

for the year ended 31 December 2025

1 ACCOUNTING POLICIES

(a) Accounting convention and basis of preparation of the accounts

The accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant notes to the accounts. The accounts have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective January 2019.

(b) Funds

General finds represent the funds of the charity that are not subject to any restrictions regarding their use and are available for application for general purposes. Funds designated for a particular purpose by the charity are also unrestricted.

(c) Incoming resources

Donations, legacies and other forms of voluntary income are recognised as incoming resources when receivable, except in so far as they are incapable of financial measurement.

Trading income is shown net of related expenses as this better reflects the contribution of these activities to the charity.

Income tax recoverable in relation to donations received under Gift Aid is recognised at the time of the donation.

Membership income is recognised in the accounting period it relates to.

(d) Resources expended

Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are those costs incurred directly in support of expenditure on the objects of the charity. Governance costs are those associated with the governance arrangements of the charity.

(e) Taxation

The charity is exempt from corporation tax on its charitable activities.

2 DONATIONS Donations	Unrestricted funds £ 38,946 38,946	Restricted funds £ - -	Total funds 2025 £ 38,946 38,946	Total funds 2024 £ 56,260 56,260

57

JCCP (limited by guarantee) Notes to the Financial Statements for the year ended 31 December 2025

3 CHARITABLE ACTIVITIES Corporate membership payments Education and training providers 4 INVESTMENT INCOME Deposit account interest 5 EXPENDITURE - Charitable activities Administrative costs Computer and marketing costs Insurance Printing and stationery Consultancy fees Training course Travel Social media Bank charges Project costs Sundry expenses	Unrestricted funds £ 56,858 16,857 73,715 Unrestricted funds £ 1,275 1,275 Unrestricted funds £ - 39,037 2,139 192 34,200 - 2,534 - - 13,802 95 91,999	Restricted funds £ - - - Restricted funds £ - - Restricted funds £ - - - - - - - - - - - -	Total funds 2025 £ 56,858 16,857 73,715 Total funds 2025 £ 1,275 1,275 Total funds 2025 £ - 39,037 2,139 192 34,200 - 2,534 - - 13,802 95 91,999	Total funds 2024 £ 32,325 39,113 71,438 Total funds 2024 £ 965 965 Total funds 2024 £ 1,800 1,932 1,838 325 28,600 1,500 2,441 4,640 102 44,170 427 87,775

58

JCCP (limited by guarantee) Notes to the Financial Statements for the year ended 31 December 2025

6 EXPENDITURE - Governance costs

Unrestricted Restricted funds funds £ £ Accountancy and book-keeping 5,880 - Legal and professional fees 17,516 - 23,396 - 7 DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade debtors Prepayments and accrued income 8 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade creditors Accrued charges and deferred income 9 MOVEMENT ON UNRESTRICTED AND RESTRICTED FUNDS Balance at 1 January Incoming Outgoing 2024 resources resources £ £ £ Unrestricted General Fund 94,675 113,936 (115,395) Restricted - - - 94,675 113,936 (115,395)	Total funds 2025 £ 5,880 17,516 23,396 2025 £ 2,500 11,077 13,577 2025 £ 6,935 28,940 35,875 Transfers between funds £ - - -	Total funds 2024 £ 5,105 15,600 20,705 2024 £ 2,000 4,253 6,253 2024 £ 1,953 34,731 36,684 Balance at 31 December 2025 £ 93,216 - 93,216

59

JCCP (limited by guarantee) Notes to the Financial Statements

for the year ended 31 December 2025

10 ANALYSIS OF NET ASSETS BETWEEN FUNDS Unrestricted General Fund Restricted	Tangible fixed assets £ - - -	Net current assets £ 93,216 - 93,216	Total £ 93,216 - 93,216

11 TRUSTEES REMUNERATION AND EXPENSES

Professor D Sines is the Executive Chair of the Management Board and received consultancy fees of £12,000 during the year (2024 : £7,000) plus reimbursed travel and administrative expenses totalling £525 during the year (2024 : £1,098).

D Knight received consultancy fees of £3,600 during the year (2024 : £3,750) and also reimbursed travel and administrative expenses of £nil during the year (2024 : £112).

A Rankin received reimbursed travel expenses totalling £942 during the year (2024 : £223).

K Cairns received reimbursed travel expenses totalling £nil during the year (2024 : £413)

12 NUMBER OF EMPLOYEES

No employees were employed during the year or the previous period.

13 OTHER INFORMATION

The JCCP is a private charitable company limited by guarantee and incorporated in England. Its registered office is:

1st Floor, Unit 12 Compass Point Ensign Way Hamble Southampton Hampshire SO31 4RA

60